Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-10-13

FDA Approved: XELSTRYM — Supplemental Application (Noven Therapeutics, LLC)

View source ↗

Summary

FDA approved a supplemental application for XELSTRYM (dextroamphetamine) from Noven Therapeutics, LLC. The snippet does not specify the exact nature of the supp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • XELSTRYM (Dextroamphetamine)

Snippet

SUPPL AP for XELSTRYM (DEXTROAMPHETAMINE)